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Conclusions: Brief therapies give faster benefits than long-term psychodynamic psychotherapy but 61 in the long run long-term psychodynamic psychotherapy is superior to brief therapies. More 62 research is, however, still needed to determine to whom long-term psychotherapy should be 63 recommended for the treatment of depressive or anxiety disorders. 64 
INTRODUCTION
Mood and anxiety disorders are prevalent and incapacitating disorders that commonly run a 66 recurrent and chronic course. 1 Different psychotherapies are widely applied in the treatment of 67 these disorders and short-term efficacy of brief psychotherapies, especially cognitive, cognitive-68 behavioral, interpersonal, and psychodynamic individual psychotherapies, have been demonstrated 69 in clinical trials. 2-4 Short-term psychodynamic psychotherapy is a brief individual psychotherapy, 70 which is widely used in ordinary clinical practice, and which has been shown to be efficient. 5-7 71 Solution-focused therapy, which was developed from therapies applying a problem solving 72 approach and systemic family therapy, 8 has been reported to produce rapid effects with reductions 73 in psychiatric symptoms after only a few sessions. 9 It has been suggested that although the efficacy 74 of brief therapies in alleviating psychiatric symptoms has been shown to be good in the short-term, 75 treatment results may not be maintained, while long-term psychotherapy may result in more 76 enduring changes. 10, 11 Non-randomized studies have, however, given inconsistent results on the 77 efficacy of long-term psychotherapy. 12, 13 Thus far, no evidence from randomized clinical trials 78 exists on the differential efficacy of short and long-term therapies and on maintenance of treatment 79 effects from brief therapies in the long run. To address this lack of evidence we conducted a 80 randomized clinical trial comparing the effect of long and short-term psychodynamic psychotherapy 81 and solution-focused therapy in the treatment of depressive and anxiety disorders and followed the 82 treatment effects during a 3-year follow-up. 6 PATIENTS AND METHODS 84 The methods used have been described in detail elsewhere 14 and are summarized briefly here. 85 Patients gave written informed consent. The project follows the Helsinki Declaration and was 86 approved by the Helsinki University Central Hospital's ethics council. 87 88 Patients and Settings 89 A total of 580 outpatients were recruited from psychiatric services in the Helsinki region from June 90 1994 to June 2000. They were referred to the project by psychiatrists working in private practice, 91 the community mental health care and student health care systems, and by occupational health 92 services. The patients represented individuals usually treated by psychotherapy in southern Finland. 93 Eligible patients were 20-45 years of age and had a long-standing (> 1 year) disorder causing social 94 dysfunction in work ability. They had to meet DSM-IV criteria 15 for anxiety or mood disorders and 95 be estimated on a psychodynamic scale of suffering from neurosis to high-level borderline disorder. 96 Patients were excluded from the study for the following reasons: psychotic disorder or severe 97 personality disorder, adjustment disorder, substance use disorders, organic brain disease or other 98 severe organic disease, and mental retardation. Individuals treated with psychotherapy within the 99 previous 2 years, psychiatric health employees and persons known to the research team members 100 were also excluded.
9
The Symptom Check List Global Severity Index (SCL-90-GSI), 21 a measure of general psychiatric 157 symptoms, was used as a secondary outcome. Other secondary measures were remission from 158 depressive symptoms and recovery from psychiatric diagnosis on axis I. Self-report remission from 159 depressive symptoms was defined as a total score of < 10 in the BDI 23 and recovery from 160 psychiatric diagnosis was assessed according to the DSM-IV diagnostic criteria 15 using a semi-161 structured interview. 162 163 Socioeconomic factors (sex, age, marital status, education, and employment status), psychiatric 164 history data (age at onset of first psychiatric symptoms, number of previous episodes, and duration 165 of symptoms), and attempted suicides were assessed at baseline using questionnaire and interview. 166 Previous psychiatric treatment (psychotherapy, psychotropic medication, and psychiatric 167 hospitalization) was also assessed. A telephone interview, including information on the symptom 168 status and the reason for the dropout (Psychiatric Symptoms Questionnaire, PSQ) was completed 169 whenever possible for each dropout patient for whom no other interview or questionnaire data were 170 available. 171 172 Statistical methods 173 It was estimated that 100 patients in the short-term psychodynamic and solution-focused therapy 174 groups and 130 in the long-term psychodynamic psychotherapy group were required to have a 95% 175 probability of detecting a significant 20% difference during a 3-year follow-up between the 3 176 groups in the BDI and SCL-90-Anx. The main analyses were based on the 'intention-to-treat', and complementary 'as treated' analyses 179 were performed. The data contained repeated measurements of the main response variables, quality 180 of study treatment, auxiliary treatments, and dropouts of patients from measurement occasions. The 10 primary analyses were based on the assumption of ignorable drop-outs. In secondary analyses 182 missing values were replaced by multiple imputation. The imputation was based on Markov chain 183 Monte Carlo methods. The variables in the imputation model were assumed to follow a multinormal 184 distribution, and the treatment groups were imputed separately. The imputation model contained the 185 outcome variable, an indicator for whether the patient received the study treatment or not, 186 discontinuation of the study treatment, the most relevant information on auxiliary treatments, and 187 the indicators Symptom Check List Global Severity Index (SCL-90-GSI) and Global Assessment of 188 Functioning scale (GAF). 15 189 190 In the case of continuous response variables, the statistical analyses were based on linear mixed 191 models, 24 and in the case of binary responses, logistic regression models and generalized estimating 192 equations estimation were used. 25 The dependencies between the design points were accounted for 193 in the case of the linear mixed models by assuming the unstructured correlation structure. In the 194 case of the logistic regression models, the alternating logistic regression method 26 with fully 195 parameterized clusters was applied. Also simpler structures were used when necessary. Several follow-up as main effects in the models. All models were carried out based on both the original data 214 and on multiple imputed data. Since no major differences were found between the different models, 215 the results presented are mainly based on the basic intention-to-treat model. Of the 580 patients referred to the project, 381 satisfied the eligibility criteria and were willing to 223 participate in the study. 14 During the waiting time (average 56 days) from the assessment of 224 eligibility to baseline examination, 55 of these decided not to participate (Figure 1) . Of the 225 remaining 326 patients, 128 were randomly assigned to long-term psychodynamic therapy, 101 to 226 short-term psychodynamic therapy, and 97 to solution-focused therapy. Of the patients randomized, 227 26 patients assigned to long-term psychotherapy and 7 assigned to brief therapies refused to 228 participate after assignment to the treatment group. Of the patients starting the assigned therapy a 229 total of 42 patients discontinued the treatment prematurely. The patients discontinuing solution-230 focused therapy had more symptoms than those continuing treatment (data not shown). The average 231 number of therapy sessions among patients starting the therapy was 232 (SD = 105) in the long-232 term psychodynamic psychotherapy, 18.5 (SD = 3.4) in the short-term psychodynamic 233 psychotherapy, and 9.8 (SD = 3.3) in the solution-focused therapy group, and the mean length of 234 therapy was 31.3 (SD = 11.9), 5.7 (SD = 1.3), and 7.5 (SD = 3.0) months, respectively. 235 236 About 60% of the patients used auxiliary treatment during the 3-year follow-up ( Table 1) . Use of 237 psychotropic medication or antidepressant medication was more common in the short-term 238 psychodynamic psychotherapy group than in the other groups and auxiliary psychotherapy was 239 more common in the two brief therapy groups than in the long-term psychodynamic psychotherapy 240 group. The average total number of therapy sessions among all patients randomized was 202 in 241 long-term psychodynamic psychotherapy, 50.8 in short-term psychodynamic psychotherapy, and 242 37.7 in solution-focused therapy, after addition of the auxiliary therapies to the treatment given by 13 the project. Only 3.1% of the patients were treated at a psychiatric hospital during the follow-up 244 and none of these patients was from the solution-focused therapy group.
246
Characteristics at baseline examination 247 The patients were relatively young and predominantly females ( Table 2) . About half of them were 248 living alone and over one-fifth had an academic education. More than half of them were either 249 employed or students. Over 80% of the patients suffered from mood disorder and over 40% from 250 anxiety disorder. No significant differences among treatment groups were found with respect to 251 baseline demographic or clinical characteristics.
253
Drop-out during follow-up 254 The mean drop-out at the 8 measurement occasions was 13% in the short-term psychodynamic 255 psychotherapy group, 18% in the long-term psychodynamic psychotherapy group, and 15% in the 256 solution-focused therapy group. The corresponding values among individuals starting the therapy 257 after randomization were 12%, 5% and 12%, respectively. Two patients from the short-term 258 psychodynamic psychotherapy group, nine from the long-term psychodynamic psychotherapy 259 group, and three from the solution-focused therapy group participated only at baseline 260 measurement. Of these 14 patients, 2 participated in the assigned therapy. Only small differences 261 were found in drop-outs between treatment groups at single points of time (Figure 2) . The major 262 reason for drop-out from a study occasion was refusal, because the study occasion was experienced 263 as mentally stressful or because the patient was disappointed with the treatment. Disappointment 264 with study treatment was statistically significantly a more common reason for drop-out in the 265 solution-focused therapy group than in the two psychotherapy groups (P < 0.001). Of the patients 266 refusing, 42% gave information on their symptoms (major psychiatric symptoms, anxiety symptoms 267 or depressive symptoms) and perceived need for psychiatric treatment by answering questions on 14 the PSQ. Symptoms and perceived need for psychiatric treatment were statistically more common 269 in the solution-focused therapy group (data not shown). A statistically significant reduction of symptoms was noted for all 5 scores considered in all three 274 treatment groups during the 3-year follow-up (P< 0.001, Table 3 ). The average score reduction was 275 51% in the BDI and 36% in the HDRS. The corresponding values for the anxiety score SCL-90- 276 Anx and the HARS were 41% and 38%, respectively. The reduction was 39% in the global measure 277 SCL-90-GSI. For all scores, the reduction was faster in the short-term therapy groups during the 278 first year of follow-up after which the reduction continued during the entire 3-year follow-up only 279 for the long-term psychodynamic psychotherapy group. 280 281 Short-term psychodynamic psychotherapy was more effective in reducing symptoms of depression 282 than long-term psychodynamic psychotherapy at the 7-12 months follow-up points, showing 283 significantly lower score values both for BDI and HDRS ( Table 3) . The mean BDI and HDRS 284 score differences between the two treatment groups after the first year of follow-up were -2.6 (CI = 285 -5.0, -0.3) and -1.9 (CI = -3.6, -0.3), respectively. During the second year of follow-up, no 286 significant differences were found between the two psychotherapy groups, and after 3 years of 287 follow-up, long-term psychodynamic psychotherapy was statistically significantly more effective 288 than short-term psychodynamic psychotherapy with 3.8 (CI = 1.4, 6.2) units lower BDI values and 289 1.9 (CI = 0.3, 3.5) units lower HDRS values in than short-term psychodynamic psychotherapy. The 290 results for anxiety symptoms and the global symptom score were similar. Short-term 291 psychodynamic psychotherapy was more effective than long-term psychodynamic psychotherapy at 292 the 7-month follow-up point with mean differences for SCL-90-Anx and HARS of -0.19 (CI = 15 -0.37, -0.01) and -1.6 (CI = -3.0, -0.2), respectively. At the 3-year follow-up point, the effectiveness 294 was reversed with mean differences of 0.20 (CI = 0.02, 0.38) for SCL-90-Anx and 1.3 (CI = -0.1, 295 2.8) for HARS. For SCL-90-GSI the difference at the 1-year time point was -0.15 (CI = -0.28, 296 -0.01) and after 3 years of follow-up 0.16 (CI = 0.01, 0.32).
298
The differences in effectiveness between long-term psychodynamic psychotherapy and solution-299 focused therapy were similar to those between short and long term psychodynamic psychotherapy 300 ( Table 3 ).The major difference was that solution-focused therapy was more effective in reducing 301 subjective depressive symptoms than long-term psychodynamic psychotherapy at an earlier stage 302 and for a shorter time period than short-term psychodynamic psychotherapy. Another difference 303 was that solution-focused therapy was no more beneficial in the treatment of anxiety symptoms 304 during the first year of follow-up. No statistically significant score differences were found between 305 the two short-term therapies at any of the 7 measurement occasions during the follow-up for any of 306 the five outcome measures considered ( Table 3) . 307 
308
The results of the comparisons between treatment groups were mainly the same in all the 309 'Intention-to-treat' models adjusting for potential confounding factors, and no significant 310 interactions between treatment group and diagnosis were found (data not shown). Also the results 311 of the 'As-treated' models, including waiting time to start of therapy, withdrawal from therapy after 312 randomization, discontinuing of treatment, and use of auxiliary treatment (i.e. psychotropic 313 medication, therapy, or hospitalization) during follow-up were similar (data not shown). Multiple 314 imputation of missing values weakened some of the associations, but the main findings remained 315 (data not shown). Remission from symptoms and recovery from diagnosis 318 Remission from depressive symptoms showed a similar pattern to the BDI and HDRS scores, but 319 16 the associations were somewhat weaker (Figure 2) . The brief therapies were statistically 320 significantly more effective than long-term psychodynamic psychotherapy during the first 7-12 321 months of follow-up, with an odds ratio (OR) of 3.21 (CI = 1.65, 6.27) for solution-focused therapy 322 at the 7-month time point and with an OR of 2.21 (CI = 1.20, 4.07) for short-term psychodynamic 323 psychotherapy at the 12-month point. At the 3-year time point the long-term psychotherapy 324 appeared to be suggestively more effective than the brief therapies, with ORs of 0.57 (CI = 0.30, 325 1.08) and 0.51 (CI = 0.25, 1.03) in comparison with the short-term psychodynamic psychotherapy 326 and the solution-focused therapy, respectively. The effect of solution-focused therapy was non-327 significantly more rapid than that of the short-term psychodynamic psychotherapy, with an OR of 328 0.52 (CI = 0.27, -1.02) after three months of follow-up. Inclusion of need for auxiliary treatment 329 among drop-outs did not notably alter the results (data not shown).
331
The study of changes in diagnoses during the follow-up showed that a statistically significantly 332 greater number of patients in the brief therapy groups recovered from mood disorder, and more 333 patients in the short-term psychodynamic psychotherapy group recovered from anxiety disorder 334 than in the long-term psychotherapy group during the first 7-12 months of follow-up (Table 4) . 335 After 3 years of follow-up, recovery from anxiety disorder was fourfold and statistically 336 significantly higher in the long-term psychodynamic psychotherapy group than in either of the brief 337 therapy groups, whereas no significant excess benefit on depression was seen in the long-term 338 psychodynamic psychotherapy group. No differences in recovery were observed between the two 339 brief therapy groups. No notable differences in results were found in the different statistical models We found a rapid and similar decrease in both self-reported and observer-rated depressive and 359 anxiety symptoms in both short-term therapies during the therapy and a less prominent reduction of 360 symptoms later on. The finding that both short-term therapies produced a comparable reduction in 361 symptoms seems to point to the fact that common beneficial ingredients in these therapies are more 362 important than specific theoretical orientation and unique ingredients in producing changes when 363 therapies are carried out by equally experienced therapists. 30 Moreover, the majority of previous 364 studies on efficacy of short-term psychodynamic psychotherapy have reported a similar rapid 365 decline in approximately 3-6 months both in depressive 31-34 and anxiety symptoms. 35, 36 18 367 The effect reached during the first few months persisted in both brief treatment groups during the 368 entire 3-year follow-up. This is in accordance with earlier studies on the efficacy of short-term 369 psychodynamic psychotherapies in which the pre-post and pre-follow-up effects have been 370 practically identical. 37 As far as we know, however, no previously published follow-up data for 371 solution-focused therapy is available. The stability in the level of psychiatric symptoms indicates 372 equal maintenance of gains but also equal lack of additional symptom improvement after both 373 short-term treatments.
375
The orientation in solution-focused therapy uses amplification of patient improvement and relies 376 heavily on a resource-oriented collaboration. 38 This highly supportive and encouraging technique is 377 probably a key factor for rapid changes early on in therapy. Accordingly, we found a more rapid 378 decrease of depressive symptoms and a more rapid remission of depression in the solution-focused 379 therapy group than in the short-term psychodynamic psychotherapy group during the first 3-7 380 months. This finding is also in agreement with previous research which has reported that in 381 comparison with other therapies the treatment effects were already seen after only a few sessions. 9
382
The rate of patients reaching remission in our study was comparable with that observed in most of 383 the previous research. 32, 39, 40 384 385
The study of the effect of treatment on diagnosis of anxiety disorders showed that long-term 386 psychodynamic psychotherapy was about 4 times as effective as the brief therapies at the 3-year 387 measurement point. No similar effect for mood disorder was noted. This far better outcome in 388 anxiety disorders could be explained by the possibility that, a more thorough approach is required 389 for the resolution of psychological conflicts related to anxiety disorders. In depression, the recovery 390 rates in all therapies were more modest. It is possible that the neurophysiological elements of experienced weaker symptoms and were therefore not willing to commit themselves for 3 years. 419 The fact that individuals discontinuing solution-focused therapy had more symptoms than those 420 completing treatment might have biased the results. Likewise, the fact that the occurrence of 421 auxiliary treatment (psychotropic medication, psychotherapy or hospitalization) was lower in the 422 long-term psychodynamic psychotherapy group during the 3-year follow-up than in the short-term 423 treatment groups was a potential source of bias. Adjustments for withdrawal, discontinuing, and 424 auxiliary treatment in 'As treated' analyses did not, however, notably alter the results from those of 425 the 'Intention-to-treat' analyses. Finally, although the rate of drop-out of patients from the 426 measurement occasions during follow-up was low, the fact that those who dropped out from the 427 solution-focused group more often had psychiatric symptoms and more often needed psychiatric 428 treatment might have biased the results in the basic 'Intention-to-treat' analyses. Analyses based on 429 multiple imputation and taking into account the need for treatment at the time of drop out did not, 430 however, notably alter the results, suggesting that the results presented are unbiased. 
